Open access
Sep 2026
ZNF217 promotes receptor tyrosine kinase plasticity and AXL-ERK dependency in ovarian cancer
It is shown that ZNF217 overexpression markedly increases ERBB2 levels in ovarian cancer cells, suggesting its potential as a biomarker to identify ovarian tumors that will respond to ERBB2-targeted therapeutics.
Megha J. Pandya, J. Hoffman, Achuth Padmanabhan
· bioRxiv · 0 citations